Disadvantages of peginterferon and ribavirin treatment in older patients with chronic hepatitis C: an analysis using the propensity score.
Ebinuma H, Saito H, Tada S, Nakamoto N, Ohishi T, Tsunematsu S, Kumagai N, Tsuchimoto K, Tsukada N, Inagaki Y, Horie Y, Takahashi M, Atsukawa K, Okamura Y, Kanai T, Hibi T.
Ebinuma H, et al. Among authors: tsuchimoto k.
Hepatol Int. 2012 Oct;6(4):744-52. doi: 10.1007/s12072-011-9312-9. Epub 2011 Sep 10.
Hepatol Int. 2012.
PMID: 22020828